Secreted Factors from Bone Marrow Stromal Cells Upregulate IL-10 and Reverse Acute Kidney Injury
Open Access
- 19 December 2012
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2012, 1-12
Abstract
Acute kidney injury is a devastating syndrome that afflicts over 2,000,000 people in the US per year, with an associated mortality of greater than 70% in severe cases. Unfortunately, standard-of-care treatments are not sufficient for modifying the course of disease. Many groups have explored the use of bone marrow stromal cells (BMSCs) for the treatment of AKI because BMSCs have been shown to possess unique anti-inflammatory, cytoprotective, and regenerative propertiesin vitroandin vivo. It is yet unresolved whether the primary mechanisms controlling BMSC therapy in AKI depend on direct cell infusion, or whether BMSC-secreted factors alone are sufficient for mitigating the injury. Here we show that BMSC-secreted factors are capable of providing a survival benefit to rats subjected to cisplatin-induced AKI. We observed that when BMSC-conditioned medium (BMSC-CM) is administered intravenously, it prevents tubular apoptosis and necrosis and ameliorates AKI. In addition, we observed that BMSC-CM causes IL-10 upregulation in treated animals, which is important to animal survival and protection of the kidney. In all, these results demonstrate that BMSC-secreted factors are capable of providing support without cell transplantation, and the IL-10 increase seen in BMSC-CM-treated animals correlates with attenuation of severe AKI.Keywords
Funding Information
- National Human Genome Research Institute (T32 HG002295, K01DK087770, R21DK085267, DK39773, DK72381)
- National Institutes of Health (T32 HG002295, K01DK087770, R21DK085267, DK39773, DK72381)
- National Institutes of Health (T32 HG002295, K01DK087770, R21DK085267, DK39773, DK72381)
- National Institutes of Health (T32 HG002295, K01DK087770, R21DK085267, DK39773, DK72381)
- National Institutes of Health (T32 HG002295, K01DK087770, R21DK085267, DK39773, DK72381)
This publication has 51 references indexed in Scilit:
- Phenotypic and functional characterization of human bone marrow stromal cells in hollow-fibre bioreactorsJournal of Tissue Engineering and Regenerative Medicine, 2011
- Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like ProfilePLOS ONE, 2010
- Long-Term Superior Performance of a Stem Cell/Hepatocyte Device for the Treatment of Acute Liver FailureTissue Engineering Part A, 2009
- Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular InjuryJournal of the American Society of Nephrology, 2009
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Intensity of Renal Support in Critically Ill Patients with Acute Kidney InjuryNew England Journal of Medicine, 2008
- Kidney injury molecule–1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cellsJournal of Clinical Investigation, 2008
- Mesenchymal Stem Cell-Derived Molecules Reverse Fulminant Hepatic FailurePLOS ONE, 2007
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingStem Cells, 2007
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005